Lilly Buys Psychedelics Maker Atai Beckley for $2.8B
Eli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
Wealth management tips can significantly boost your investment returns. Explore strategies designed for savvy investors.
26,684 articlesEli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
Small, nearly unknown biotech stocks can surge when their pipeline milestones hit. This guide breaks down how to spot...
NVIDIA signals a major pivot away from China as export controls tighten and domestic AI chip ambitions surge, a move ...
A high-stakes legal battle unfolds as Anthropic files a suit against the Department of Defense after a supply chain r...
Williams Projects a robust 2026 as U.S. natural gas output and LNG demand surge, underscoring the country’s energy se...
Royal Caribbean enters 2026 with strong demand, but fuel cost headwinds and a heavy capex slate threaten margins, rem...
Celsius Holdings has fallen hard, leaving some investors wondering if a rebound is possible. This guide breaks down t...
AXIA Energia completes its transition to 100% renewable power after divesting coal, delivering robust cash flow and e...
A once-niche software play may be quietly building a full AI-driven financial platform. This software stock could del...
As AI compute demand surges, a group of top tech firms are guided by female CFOs who balance growth with profitabilit...
NIO posted a 62% year-over-year jump in May deliveries, sending stock higher as it rolls out new models. Tesla edged ...
AMD beats just 2030’s earnings target two years ahead as AI-driven data center growth accelerates. Here's what it mea...